GuanfacineExtended-Release (Sandoz Inc)
Welcome to the PulseAid listing for the Guanfacine drug offered from Sandoz Inc. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | Guanfacine |
SUBSTANCE NAME: | GUANFACINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-06-03 |
END MARKETING DATE: | 0000-00-00 |
Guanfacine Extended-Release HUMAN PRESCRIPTION DRUG Details:
Item Description | Guanfacine Extended-Release from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/1) |
START MARKETING DATE: | 2015-06-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-5451_b0ea8a87-f0b7-4bdb-bd80-c1c40d5a213d |
PRODUCT NDC: | 0781-5451 |
APPLICATION NUMBER: | ANDA202568 |
Other GUANFACINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: